CORPORATE NEWS

CarraShield Labs Granted U.S. Patent for Anti-viral Protective Gel

September 23, 2020

CarraShield Labs, Inc. announced today that Chief Science Officer Dr. Mario Tremblay has been issued a U.S. patent for a radically new gel technology that has been shown to block HPV infections in clinical trials. This is the first non-vaccine treatment ever developed for preventing cancer-causing HPV infections in a form that can be easily applied topically by both men and women of any age.  Read more...

Clinical Results Show Divine 9 is a Breakthrough in HPV Prevention

March 11, 2019

New research results from the McGill University Medical School now shows that women can reduce the risk of contracting cancer-causing HPV infections by using Divine 9® personal lubricant with its proprietary CarraShield® sea algae extract.  The McGill team has studied the long term use of Divine 9 by hundreds of women.  The McGill team found that using Divine 9 personal lubricant in each intimate encounter significantly reduced the number of new HPV infections as compared to using a standard lubricant.

Revolutionary Study on Preventing Transmission of Cancer-causing HPV Using CarraShield Labs' Divine 9 Lubricant Launches at Rutgers and Albert Einstein Medical Schools

February 16, 2017

Distinguished research teams at Rutgers University New Jersey Medical School and Albert Einstein College of Medicine have launched a new study on preventing transmission of cancer-causing HPV during sexual activity using Divine 9® personal lubricant, which is made with a proprietary sea algae extract called CarraShield®. The researchers selected Divine 9 based on results from earlier National Cancer Institute laboratory testing that showed CarraShield prevented HPV transmission.

1 / 3

Please reload

PRESS COVERAGE

 

WHAT PEOPLE ARE SAYING...

1/4

CONNECT WITH DIVINE 9

  • Facebook Classic
  • Twitter Classic

CONTACT CARRASHIELD LABS WITH QUESTIONS, SUGGESTIONS OR ISSUES AND WE WILL BE GLAD TO HELP

© 2000-2017 CarraShield Labs, Inc.